Literature DB >> 29240296

Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.

Guimin Zhang1,2, Yin Zhao1,3, Sathish Paramasivan1, Katharina Richter1, Sandra Morales4, Peter-John Wormald1, Sarah Vreugde1.   

Abstract

BACKGROUND: Bacteriophage (phage) therapy has been proposed as an alternative to antibiotics. Phages have been shown to kill antibiotic resistant Staphylococcus aureus strains; however, it is unknown whether stress-induced antibiotic tolerance affects S. aureus susceptibility to phages. Our objective was to determine the effectiveness of 2 phages currently in clinical development, against antibiotic-resistant and induced antibiotic-tolerant clinical S. aureus isolates.
METHODS: Antibiotic tolerant S. aureus strains were induced by incubation with increasing concentrations of gentamicin, mupirocin, and ciprofloxacin over time and their susceptibility to 2 clinically relevant phages (Sa83 and Sa87) was assessed. In addition, phage susceptibility was tested in relation to the antibiotic sensitivity of 65 clinical S. aureus isolates, harvested from the sinonasal cavities of chronic rhinosinusitis (CRS) patients. Phage sensitivity was assessed using a plaque spot assay and by measuring optical density values to observe planktonic S. aureus growth in the presence of the phage. Alamar Blue assays were used to assess biofilm viability after phage treatment.
RESULTS: Frequency of antibiotic resistance amongst clinical S. aureus isolates was 90.7% (59/65) with 13 of 65 (20.0%) identified as multidrug-resistant. Tolerance to gentamicin, mupirocin, and ciprofloxacin was rapidly induced by incubation with increasing concentrations of respective antibiotics. There was no significant difference in phage sensitivity between antibiotic-sensitive and resistant/tolerant S. aureus clinical isolates in planktonic and biofilm form.
CONCLUSION: Clinical S. aureus isolates from CRS patients have a high (20%) incidence of multidrug resistance. Antibiotic resistance or tolerance did not affect phage susceptibility of those isolates.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  Staphylococcus aureus; bacteriophage; biofilm; chronic rhinosinusitis; resistance

Mesh:

Substances:

Year:  2017        PMID: 29240296     DOI: 10.1002/alr.22046

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  11 in total

1.  PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium.

Authors:  Bartłomiej Grygorcewicz; Marta Roszak; Rafał Rakoczy; Adrian Augustyniak; Maciej Konopacki; Joanna Jabłońska; Natalia Serwin; Elżbieta Cecerska-Heryć; Marian Kordas; Katarzyna Galant; Barbara Dołęgowska
Journal:  Arch Microbiol       Date:  2022-06-24       Impact factor: 2.552

2.  The in vitro antibacterial effect of permethrin and formaldehyde on Staphylococcus aureus.

Authors:  Philip Nikolic; Poonam Mudgil; John Whitehall
Journal:  Microbiologyopen       Date:  2020-05-07       Impact factor: 3.139

3.  Exacerbations of Chronic Rhinosinusitis-Microbiology and Perspectives of Phage Therapy.

Authors:  Joanna Szaleniec; Agnieszka Gibała; Monika Pobiega; Sylwia Parasion; Jacek Składzień; Paweł Stręk; Tomasz Gosiewski; Maciej Szaleniec
Journal:  Antibiotics (Basel)       Date:  2019-10-05

Review 4.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

Review 5.  Phage therapy as a revolutionary medicine against Gram-positive bacterial infections.

Authors:  Archana Loganathan; Prasanth Manohar; Kandasamy Eniyan; C S VinodKumar; Sebastian Leptihn; Ramesh Nachimuthu
Journal:  Beni Suef Univ J Basic Appl Sci       Date:  2021-08-28

Review 6.  Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia.

Authors:  Mark B Carascal; Donna May Dela Cruz-Papa; Roland Remenyi; Mely Cherrylynne B Cruz; Raul V Destura
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

Review 7.  In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.

Authors:  Eoghan Casey; Douwe van Sinderen; Jennifer Mahony
Journal:  Viruses       Date:  2018-03-30       Impact factor: 5.048

8.  Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections.

Authors:  Susan M Lehman; Gillian Mearns; Deborah Rankin; Robert A Cole; Frenk Smrekar; Steven D Branston; Sandra Morales
Journal:  Viruses       Date:  2019-01-21       Impact factor: 5.048

Review 9.  Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.

Authors:  Olivier Patey; Shawna McCallin; Hubert Mazure; Max Liddle; Anthony Smithyman; Alain Dublanchet
Journal:  Viruses       Date:  2018-12-28       Impact factor: 5.048

10.  APTC-EC-2A: A Lytic Phage Targeting Multidrug Resistant E. coli Planktonic Cells and Biofilms.

Authors:  Karen Hon; Sha Liu; Sophie Camens; George Spyro Bouras; Alkis James Psaltis; Peter-John Wormald; Sarah Vreugde
Journal:  Microorganisms       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.